Thermo Fisher Scientific Inc

TMO

Equity

ISIN null / Valor 977576

New York Stock Exchange, Inc (2025-11-21)

USD 587.48+2.57%

Thermo Fisher Scientific Inc
UMushroom community rating:

4.00 1 votes No rating yet

NegativeNeutralPositive

About company

Thermo Fisher Scientific Inc. is a prominent global provider of scientific instruments, reagents, and laboratory services, catering to the life sciences, biotechnology, and pharmaceutical sectors. With annual revenues exceeding $40 billion and a workforce of over 90,000 employees, the company offers a comprehensive range of products and services through its well-known brands such as Thermo Scientific, Applied Biosystems, Invitrogen, and Fisher Scientific. Thermo Fisher supports diverse scientific endeavors, including life sciences research, analytical challenges, diagnostics, and the development and manufacturing of therapies. Additionally, the company provides extensive pharmaceutical services, including contract development and manufacturing (CDMO), clinical trial solutions, and end-to-end drug development offerings that encompass active pharmaceutical ingredients (API), biologics, and commercial manufacturing across more than 65 global locations.

Summarized from source with an LLMView SourceSector: Technology

Revenue Growth

The company's second-quarter revenue increased by 3% to $10.85 billion, demonstrating solid performance compared to $10.54 billion in the same period of the previous year.

Earnings Performance

GAAP diluted earnings per share rose by 6% to $4.28, while adjusted EPS was $5.36, reflecting Thermo Fisher's robust profitability.

Operational Excellence

Thermo Fisher delivered excellent operational performance by actively managing costs and leveraging the PPI Business System to navigate the current macroenvironment effectively.

Strategic Partnerships

The company expanded its strategic partnership with Sanofi by acquiring the Ridgefield, New Jersey sterile fill-finish site, enhancing its capacity to meet growing demand from pharmaceutical and biotech customers.

Summarized from source with an LLMView Source

Key figures

13.8%1Y

9.55%3Y

30.3%5Y

Performance

32.2%1Y

25.7%3Y

26.7%5Y

Volatility